Dovato European Union - Norwegian - EMA (European Medicines Agency)

dovato

viiv healthcare b.v. - dolutegravir natrium, lamivudin - hiv-infeksjoner - antivirale midler til systemisk bruk - dovato er angitt for behandling av humant immunsviktvirus type 1 (hiv-1) - infeksjon hos voksne og ungdom over 12 år som veier minst 40 kg, med ingen kjent eller mistenkt resistens mot integrase inhibitor klassen, eller lamivudine.

Tecartus European Union - Norwegian - EMA (European Medicines Agency)

tecartus

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfom, mantelcelle - antineoplastiske midler - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Breyanzi European Union - Norwegian - EMA (European Medicines Agency)

breyanzi

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastiske midler - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.

Vitalipid Infant Norway - Norwegian - Statens legemiddelverk

vitalipid infant

fresenius kabi norge as - halden - tokoferol, helracemisk, a- / retinylpalmitat / fytomenadion / ergokalsiferol - konsentrat til infusjonsvæske, emulsjon - 640 mikrog/ ml / 69 mikrog/ ml / 20 mikrog/ ml / 1 mikrog/ ml

Voltarol 140 mg Norway - Norwegian - Statens legemiddelverk

voltarol 140 mg

glaxosmithkline consumer healthcare a/s (1) - diklofenaknatrium - medisinert plaster - 140 mg

Pepcidduo Norway - Norwegian - Statens legemiddelverk

pepcidduo

mcneil sweden ab - famotidin / magnesiumhydroksid / kalsiumkarbonat - tyggetablett med spearmintsmak - 10 mg / 165 mg / 800 mg

Clariscan 0.5 mmol/ ml Norway - Norwegian - Statens legemiddelverk

clariscan 0.5 mmol/ ml

ge healthcare as - gadoteratmeglumin - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 0.5 mmol/ ml

Clariscan 0.5 mmol/ ml Norway - Norwegian - Statens legemiddelverk

clariscan 0.5 mmol/ ml

ge healthcare as - gadoteratmeglumin - injeksjonsvæske, oppløsning - 0.5 mmol/ ml

Dotarem 279.3 mg/ ml Norway - Norwegian - Statens legemiddelverk

dotarem 279.3 mg/ ml

guerbet - gadoteratmeglumin - injeksjonsvæske, oppløsning - 279.3 mg/ ml

Gadovist 1 mmol/ ml Norway - Norwegian - Statens legemiddelverk

gadovist 1 mmol/ ml

bayer ab - solna - gadobutrol - injeksjonsvæske, oppløsning - 1 mmol/ ml